• ქართული
  • English
  • Mylan to combine with Pfizer's off-patent medicines unit

    Mylan NV said on Monday it would combine with Pfizer Inc’s off-patent branded and generic established medicines business to form a global generic drugmaker.

    Market Quotes by TradingView